Back
Barclays PLC Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
63
BCLYF
Barclays PLC
Last Price:
$3.99
Seasonality Move:
10.64%
Buy
53
ALNY
Alnylam Pharmaceuticals
Last Price:
$269.17
Seasonality Move:
3.3%
Buy
63
Barclays PLC (BCLYF)
is a Buy
Is Barclays PLC a Buy, Sell or Hold?
-
The current Barclays PLC [BCLYF] share price is $4.02. The Score for BCLYF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
BCLYF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $280.96. The Score for ALNY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCLYF Stock Price Chart
What is Barclays PLC's stock price today?
-
The Barclays PLC share price today is $4.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCLYF is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $280.96The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
BCLYF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 56.37 | Buy |
| Chaikin Money Flow: | -12298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.7 - 3.98) | Buy |
| Bollinger Bands (100): | (3.22 - 3.76) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.18 | Buy |
| Relative Strength Index (14 RSI): | 64.02 | Buy |
| Chaikin Money Flow: | -956276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (237.98 - 264.74) | Buy |
| Bollinger Bands (100): | (240.44 - 271.42) | Buy |
BCLYF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.86 | Buy |
| 20-day SMA: | 3.84 | Buy |
| 50-day SMA: | 3.7 | Buy |
| 200-day SMA: | 3.17 | Buy |
| 8-day EMA: | 3.87 | Buy |
| 20-day EMA: | 3.83 | Buy |
| 50-day EMA: | 3.71 | Buy |
| 200-day EMA: | 3.21 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 262.64 | Buy |
| 20-day SMA: | 251.27 | Buy |
| 50-day SMA: | 258.44 | Buy |
| 200-day SMA: | 252.16 | Buy |
| 8-day EMA: | 267.69 | Buy |
| 20-day EMA: | 258.45 | Buy |
| 50-day EMA: | 256.39 | Buy |
| 200-day EMA: | 243.81 | Buy |
Barclays PLC Earnings Growth & BCLYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Barclays PLC Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||